ArticleBJR open2024

Patient, tumour, and dosimetric factors influencing survival in non-small cell lung cancer patients treated with stereotactic ablative body radiotherapy.

Minal Padden-Modi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.